Simon Thebault MBBCh, FRCPC
Simon Thebault MBBCh, FRCPC
University of Pensylvania
Verified email at
Cited by
Cited by
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
S Thebault, M Abdoli, SM Fereshtehnejad, D Tessier, V Tabard-Cossa, ...
Scientific reports 10 (1), 10381, 2020
Blood neurofilament light chain: the neurologist’s troponin?
S Thebault, RA Booth, MS Freedman
Biomedicines 8 (11), 523, 2020
Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis
S Meier, EAJ Willemse, S Schaedelin, J Oechtering, J Lorscheider, ...
JAMA neurology 80 (3), 287-297, 2023
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
S Thebault, D Tessier, L Hyunwoo, M Bowman, A Bar-Or, D Arnold, ...
Neurology Neuroimmunology and Neuroinflammation 6, e598, 2019
Serum neurofilament light in MS: The first true blood-based biomarker?
S Thebault, G Bose, R Booth, MS Freedman
Multiple Sclerosis Journal 28 (10), 1491-1497, 2022
Serum neurofilament light chain measurement in MS: hurdles to clinical translation
S Thebault, RA Booth, CA Rush, H MacLean, MS Freedman
Frontiers in Neuroscience 15, 654942, 2021
Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination
S Thebault, P Waters, MD Snape, D Cottrell, N Darin, T Hallb÷÷k, ...
PLoS One 10 (6), e0129555, 2015
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
S Thebault, H Lee, G Bose, D Tessier, M Abdoli, M Bowman, J Berard, ...
Annals of Clinical and Translational Neurology 7 (5), 767-775, 2020
High or increasing serum NfL is predictive of impending multiple sclerosis relapses
S Thebault, M Reaume, RA Marrie, JJ Marriott, R Furlan, A Laroni, ...
Multiple Sclerosis and Related Disorders 59, 103535, 2022
Narcolepsy and H1N1 vaccination: a link?
S Thebault, A Vincent, P Gringras
Current opinion in pulmonary medicine 19 (6), 587-593, 2013
Autologous hematopoietic stem cell transplantation for multiple sclerosis: a current perspective
G Bose, S Thebault, CA Rush, HL Atkins, MS Freedman
Multiple Sclerosis Journal 27 (2), 167-173, 2021
Neurofilaments as biomarkers in neurological disorders—towards clinical application
M Khalil, CE Teunissen, S Lehmann, M Otto, F Piehl, T Ziemssen, ...
Nature Reviews Neurology, 1-19, 2024
Implications of low-titer MOG antibodies
M Levy, EA Yeh, CH Hawkes, J Lechner-Scott, G Giovannoni
Multiple sclerosis and related disorders 59, 2022
Does resetting the immune system fix multiple sclerosis?
G Bose, SDX Thebault, HL Atkins, MS Freedman
Canadian Journal of Neurological Sciences 47 (1), 1-10, 2020
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy
A Reilly, MO Deguise, A Beauvais, R Yaworski, S Thebault, DR Tessier, ...
Gene Therapy 29 (9), 544-554, 2022
Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma.
S Thebault, I Hanes, J Woulfe, P Bourque
Neurology: Neuroimmunology and Neuroinflammation 6 (1), e527, 2018
Complement‐induced protection: an explanation for the limitations of cell‐based tumour immunotherapies
E Kempshall, S Thebault, B Paul Morgan, CL Harris, A Gallimore
Immunology and Cell Biology 90 (9), 869-871, 2012
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury
D Wilson, D Chan, L Chang, R Mathis, I Verberk, X Montalban, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 62 (2), 322-331, 2024
Blood neurofilament light chain: the Neurologist’s Troponin? Biomedicines 8 (11): 523
S Thebault, RA Booth, MS Freedman
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS. Neurol Neuroimmunol Neuroinflamm 6 (5)
S Thebault, LH D RT, M Bowman, A Bar-Or, DL Arnold, TCV H LA, ...
The system can't perform the operation now. Try again later.
Articles 1–20